Similar articles

• Response of undifferentiated thyroid carcinoma to combined modality treatment. Invited commentary.

  Thomas CG Jr. Thomas CG Jr. World J Surg. 1979 Aug 31;3(4):521-2. doi: 10.1007/BF01556125. World J Surg. 1979. PMID: 516772 No abstract available.
• Response to undifferentiated thyroid carcinoma to combined modality treatment.

  Brun JG, Barre Y, Barre T, Mogenet M, Reynier J. Brun JG, et al. World J Surg. 1979 Aug 31;3(4):517-20. doi: 10.1007/BF01556123. World J Surg. 1979. PMID: 516770 No abstract available.
• Medical therapy for differentiated thyroid carcinoma.

  Dulgeroff AJ, Hershman JM. Dulgeroff AJ, et al. Endocr Rev. 1994 Aug;15(4):500-15. doi: 10.1210/edrv-15-4-500. Endocr Rev. 1994. PMID: 7988483 Review.
• Undifferentiated sarcoma of the thyroid in a child.

  Postovsky S, Vlodavsky E, Kuten A, Shendler Y, Doweck I, Ben Arush MW. Postovsky S, et al. Pediatr Blood Cancer. 2010 Jul 1;54(7):1038-40. doi: 10.1002/pbc.22435. Pediatr Blood Cancer. 2010. PMID: 20127848
• Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission.

  Mould RC, van Vloten JP, AuYeung AWK, Karimi K, Bridle BW. Mould RC, et al. Endocr Relat Cancer. 2017 Dec;24(12):T311-T329. doi: 10.1530/ERC-17-0316. Epub 2017 Sep 14. Endocr Relat Cancer. 2017. PMID: 28912377 Review.